Skip to main content

Table 2 Comparison of gait measures between MS and control groups in the laboratory and during daily life

From: Laboratory versus daily life gait characteristics in patients with multiple sclerosis, Parkinson’s disease, and matched controls

Gait measures

Laboratory

Daily Life

MS-Ctl

(N = 16)

MS

(N = 15)

Wilcox

p-value

MS-Ctl

(N = 16)

MS

(N = 15)

Wilcox

p-value

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Cadence (steps/min)

114.11 

9.69

112.59 

10.9

0.770

106.92 

8.36

99.57 

7.68

0.005

Double Support (%)

20.3 

2.65

22.06

4

0.129

22.67 

3.55

26.85 

3.61

0.002†

Elevation at Mid Swing (cm)

0.81 

0.32

1.07 

0.47

0.155

2.98 

0.69

2.71 

0.53

0.299

Gait Speed (m/s)

1.11 

0.15

1 

0.16

0.097

1 

0.17

0.8 

0.13

0.001†

Foot Strike Angle (degrees)

17.97 

3.34

15.65 

4.68

0.188

19.38 

2.64

16.25 

4.16

0.037

Toe Off Angle (degrees)

36.31 

3.44

31.85 

3.97

0.004†

27.97 

3.83

23.96 

4.01

0.017

Stride Duration (s)

1.06 

0.09

1.08 

0.11

0.767

1.17 

0.1

1.25 

0.1

0.017

Stride Length (m)

1.16 

0.11

1.07 

0.13

0.027

1.1 

0.16

0.95 

0.15

0.019

Swing (%)

39.84 

1.34

38.91 

2.1

0.123

38.81 

1.85

36.58 

1.85

0.002†

Toe Out Angle (degrees)

9.57 

4.45

11.13 

6.16

0.358

17.93 

8.47

18.89 

11.51

0.599

Lumbar—Coronal ROM (degrees)

8.47 

1.45

7.22 

1.91

0.040

7.45 

1.72

6.31

 1.72

0.151

Lumbar—Sagittal ROM (degrees)

6.18 

2.26

6.15 

1.86

0.752

6.87 

1.15

6.87 

1.15

0.740

Lumbar—Transverse ROM (deg)

8.75 

2.85

9.79 

2.57

0.286

16.62 

2.87

16.62 

1.72

0.338

  1. Italics indicates p < 0.05, and † indicates if the p-value ≤ 0.004 level of significance after Bonferroni correction (that is, 0.05/13 = 0.004)
Back to article page

Journal of NeuroEngineering and Rehabilitation

ISSN: 1743-0003

Contact us